Cell, gene therapy company funding reaches new heights, despite setbacks
Dive Brief:• Biotech developers of cell, gene and regenerative therapies raised $14 billion in funding over the first six months of 2021, an enormous …
Industry News
The gene therapy revolution in healthcare
Gene therapy offers millions of people with life-threatening rare diseases the potential for longer, healthier lives. But while the therapeutic …
New gene therapies may soon treat dozens of rare diseases, but million-dollar price tags will put them out of reach for many
Zolgensma – which treats spinal muscular atrophy, a rare genetic disease that damages nerve cells, leading to muscle decay – is currently the most …
The incredible origin story of CRISPR
A biotech startup has received $15 million in funding to genetically recreate woolly mammoths and rewild them in Siberia. It marks a breakthrough in …
Gene Therapy Is Coming of Age
Gene therapy has come a long way since its first human proof-of-concept trials in the 1990s. The approach—which involves fixing or replacing a …
Four Success Stories in Gene Therapy
After numerous setbacks at the turn of the century, gene therapy is treating diseases ranging from neuromuscular disorders to cancer to blindness. …
The Basics of Hemophilia A
Hemophilia A is a disorder that makes a person predisposed to bleeding. This can cause issues ranging from prolonged bleeding from a minor wound to …